Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3997]

Abemaciclib combined with endocrine therapy improves OS in high-risk HR+, HER2−...

Prof Stephen Johnston - The Royal Marsden, London, UK

Abemaciclib combined with endocrine therapy improves OS in high-risk HR+, HER2− early breast cancer ( Prof Stephen Johnston - The Royal Marsden, London, UK )

Avelumab maintenance after reduced chemotherapy cycles improves QoL without...

Dr Enrique Grande - MD Anderson Cancer Center Madrid, Madrid, Spain

Avelumab maintenance after reduced chemotherapy cycles improves QoL without sacrificing survival in aUC ( Dr Enrique Grande - MD Anderson Cancer Center Madrid, Madrid, Spain )

Durvalumab combined with FLOT improves survival in resectable gastric and GEJ...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

Enhancing breast cancer care through AI and collaboration

Dr Gabrielle Speijer, Dr Fernando Suarez and Dr Tolga Ozmen

Enhancing breast cancer care through AI and collaboration ( Dr Gabrielle Speijer, Dr Fernando Suarez and Dr Tolga Ozmen )

Proton vs photon radiotherapy shows similar patient-reported quality of life in...

Dr Shannon MacDonald - Southwest Florida Proton Center, Florida, USA

Proton vs photon radiotherapy shows similar patient-reported quality of life in breast cancer patients ( Dr Shannon MacDonald - Southwest Florida Proton Center, Florida, USA )

NSCLC brain metastases: TTFields after SRS delays intracranial progression...

Dr Vinai Gondi - Northwestern Medicine West Region and Proton Center, Illinois...

NSCLC brain metastases: TTFields after SRS delays intracranial progression without affecting QoL ( Dr Vinai Gondi - Northwestern Medicine West Region and Proton Center, Illinois, USA )

Apalutamide and salvage radiotherapy benefits luminal B subtype prostate cancer

Prof Daniel Spratt - University Hospitals Cleveland Medical Center, Cleveland...

Apalutamide and salvage radiotherapy benefits luminal B subtype prostate cancer ( Prof Daniel Spratt - University Hospitals Cleveland Medical Center, Cleveland, USA )

ctDNA testing improves detection of treatable metastases compared to standard...

Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA

ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer ( Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA )

ADT with PORT is a good treatment option for men with unfavourable intermediate...

Dr Mack Roach III - University of California San Francisco, San Francisco, USA

ADT with PORT is a good treatment option for men with unfavourable intermediate risk or favourable high risk PC ( Dr Mack Roach III - University of California San Francisco, San Francisco, USA )

Bladder cancer updates from the first half of 2025

Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone...

Bladder cancer updates from the first half of 2025 ( Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Benjamin Pradere )

Improving efficacy and toxicity reporting - and treatment insights from an...

Dr Ross Camidge - University of Colorado School of Medicine, Aurora, Colorado

Improving efficacy and toxicity reporting - and treatment insights from an oncologist patient ( Dr Ross Camidge - University of Colorado School of Medicine, Aurora, Colorado )

CURB phase II trial: Tumour burden predicts survival after SBRT in NSCLC...

Dr Matthew McMillan - Memorial Sloan-Kettering Cancer Center, New York, USA

CURB phase II trial: Tumour burden predicts survival after SBRT in NSCLC oligoprogression ( Dr Matthew McMillan - Memorial Sloan-Kettering Cancer Center, New York, USA )

More from ecancer